NCT07192172View on ClinicalTrials.gov

Enhanced Radiofrequency Ablation for Recurrent HCC Post-TACE Using Twin Internally Cooled-Perfusion Electrodes

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

September 1, 2017

Primary Completion Date

January 31, 2019

Study Completion Date

December 1, 2020

Conditions
Recurrent HCCAblation Techniques, RFA
Interventions
DEVICE

Bipolar radiofrequency ablation using twin internally cooled perfusion electrodes

"Device: Twin Internally Cooled-Perfusion (TICP) Electrodes~Two 17-gauge internally cooled-perfusion electrodes Multichannel RF generator (RF Medical Co., Seoul, Korea) Bipolar mode application Saline perfusion rate: approximately 1 cc/min"

Trial Locations (1)

03080

Seoul National University Hosptial, Seoul

All Listed Sponsors
lead

Seoul National University Hospital

OTHER

NCT07192172 - Enhanced Radiofrequency Ablation for Recurrent HCC Post-TACE Using Twin Internally Cooled-Perfusion Electrodes | Biotech Hunter | Biotech Hunter